Literature DB >> 17341483

Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome.

Marcus G Pezzolesi1, Kevin M Zbuk, Kristin A Waite, Charis Eng.   

Abstract

Germline mutations in PTEN, encoding a phosphatase on 10q23, cause Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRRS). Approximately, 10% of CS-related PTEN mutations occur in the PTEN promoter and 11% of BRRS-related mutations include large deletions, often favoring the gene's 5' end (exon 1, promoter). In order to better understand the mechanism(s) underlying the deregulation of PTEN in these syndromes, it is important that functional cis-regulatory elements be identified. We employed a comparative genomic approach combined with molecular genetic techniques to identify a highly conserved sequence upstream of the PTEN promoter, sharing 80% sequence identity among Homo sapiens, Mus musculus and Rattus norvegicus. Within this region, we identified a canonical E-box sequence (CACGTG) located at position -2181 to -2176, approximately 800 bp upstream of the PTEN core promoter and more than 1.1 kb upstream of its minimal promoter region (located at -958 to -821). In vitro assays suggest that this motif is recognized by members of the basic region-helix-loop-helix-leucine-zipper (bHLH-LZ) transcription factor family, USF1 and USF2, and reporter assays indicate that this novel E-box is involved in mediating PTEN transcriptional activation. Four of 30 CS/CS-like patients, without previously identified PTEN mutations, were found with germline deletions of the E-box element. Of the four, three had deletions stretching to exon 1, but not 3' of it; importantly, one classic CS patient harbored a germline deletion localizing to this E-box region, further affirming the role of this element in PTEN's regulation and deregulation, and its contribution to the pathogenesis of CS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17341483     DOI: 10.1093/hmg/ddm053

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  20 in total

1.  PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?

Authors:  Lamis Yehia; Charis Eng
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

2.  Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case-control study.

Authors:  Xiaodong Zhao; Tianyi Wang; Bo Liu; Zhenzhou Wu; Shuo Yu; Tao Wang
Journal:  Tumour Biol       Date:  2014-12-06

3.  MicroRNA-23a promotes myelination in the central nervous system.

Authors:  Shu-Ting Lin; Yong Huang; Luoying Zhang; Mary Y Heng; Louis J Ptácek; Ying-Hui Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

4.  Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study.

Authors:  Virginie Caux-Moncoutier; Sabine Pagès-Berhouet; Dorothée Michaux; Bernard Asselain; Laurent Castéra; Antoine De Pauw; Bruno Buecher; Marion Gauthier-Villars; Dominique Stoppa-Lyonnet; Claude Houdayer
Journal:  Eur J Hum Genet       Date:  2009-05-27       Impact factor: 4.246

5.  Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome.

Authors:  Marcus G Pezzolesi; Petra Platzer; Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2008-05       Impact factor: 11.025

6.  Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.

Authors:  Rosemary E Teresi; Kevin M Zbuk; Marcus G Pezzolesi; Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2007-08-15       Impact factor: 11.025

7.  PPARgamma, PTEN, and the Fight against Cancer.

Authors:  Rosemary E Teresi; Kristin A Waite
Journal:  PPAR Res       Date:  2008-12-14       Impact factor: 4.964

8.  Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening.

Authors:  Maria Marchese; Valerio Conti; Giulia Valvo; Francesca Moro; Filippo Muratori; Raffaella Tancredi; Filippo M Santorelli; Renzo Guerrini; Federico Sicca
Journal:  BMC Med Genet       Date:  2014-02-27       Impact factor: 2.103

9.  Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma.

Authors:  Durmus Burgucu; Kenan Guney; Duygu Sahinturk; Irem Hicran Ozbudak; Deniz Ozel; Gulay Ozbilim; Ugur Yavuzer
Journal:  BMC Cancer       Date:  2012-10-19       Impact factor: 4.430

10.  Differential gene expression profiling of enriched human spermatogonia after short- and long-term culture.

Authors:  Sabine Conrad; Hossein Azizi; Maryam Hatami; Mikael Kubista; Michael Bonin; Jörg Hennenlotter; Markus Renninger; Thomas Skutella
Journal:  Biomed Res Int       Date:  2014-03-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.